Patents by Inventor Linda Thorne
Linda Thorne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20080073212Abstract: Gellan can be purified from nucleic acid contamination by combining the contaminated gellan with DNase under conditions that allow the DNase to degrade the nucleic acid contaminant. The purified gellan is useful in gel electrophoresis. A buffer which allows cystamine to be used as a reversible cross-linker does not have to be recirculated during the course of a normal gel run.Type: ApplicationFiled: November 30, 2007Publication date: March 27, 2008Applicant: SHIN-ETSU CHEMICAL COMPANY, LTDInventors: Linda Thorne, Richard Armentrout
-
Patent number: 7326324Abstract: Gellan can be purified from nucleic acid contamination by combining the contaminated gellan with DNase under conditions that allow the DNase to degrade the nucleic acid contaminant. The purified gellan is useful in gel electrophoresis. A buffer which allows cystamine to be used as a reversible cross-linker does not have to be recirculated during the course of a normal gel run.Type: GrantFiled: November 20, 2003Date of Patent: February 5, 2008Assignee: Shin-Etsu Chemical Co., Ltd.Inventors: Linda Thorne, Richard W Armentrout
-
Publication number: 20040168920Abstract: Gellan can be purified from nucleic acid contamination by combining the contaminated gellan with DNase under conditions that allow the DNase to degrade the nucleic acid contaminant. The purified gellan is useful in gel electrophoresis. A buffer which allows cystamine to be used as a reversible cross-linker does not have to be recirculated during the course of a normal gel run.Type: ApplicationFiled: November 20, 2003Publication date: September 2, 2004Applicant: Shin-Etsu Chemical Company, LtdInventors: Linda Thorne, Richard W. Armentrout
-
Patent number: 6284516Abstract: The present invention relates to DNA segments isolated from Sphingomonas sp. and involved in the biosynthetic production of sphingan polysaccharides to increase the production of the polysaccharide in engineered microorganisms. The present invention also relates to methods of engineering strains of Sphingomonas to produce bacteria which are hyperproducers of sphingan, methods of identifying and utilizing DNA fragments useful to enhance production of sphingan in bacteria and the hyperproducer bacteria.Type: GrantFiled: November 15, 1999Date of Patent: September 4, 2001Assignees: Shin-Etsu Bio, Inc., Shin-Etsu Chemical. Co., Ltd.Inventors: Thomas J. Pollock, Motohide Yamazaki, Linda Thorne, Marcia Mikolajczak, Richard W. Armentrout
-
Patent number: 6030817Abstract: A new recombinant bacteria for the production of exopolysaccharides is disclosed as well as a method for making the recombinant bacteria and making an exopolysaccharide from the bacteria by submerged aerobic fermentation of the bacteria utilizing a sugar substrate. The exopolysaccharides obtained from the inventive bacteria exhibit improved, more desirable or different properties from the exopolysaccharide produced by the non-recombinant bacteria from which the recombinant bacteria was derived. In addition, the present invention provides a method of producing bacterial exopolysaccharides by fermentation from sugar substrates that the bacteria which the exopolysaccharides are native to cannot utilize.Type: GrantFiled: June 11, 1998Date of Patent: February 29, 2000Assignees: Shin-Etsu Bio, Inc., Shin-Etsu Chemical Co., Ltd.Inventors: Thomas J. Pollock, Marcia Mikolajczak, Motohide Yamazaki, Linda Thorne, Richard W. Armentrout
-
Patent number: 6027925Abstract: A recombinant bacteria for the production of exopolysaccharides is disclosed as well as a method for making the recombinant bacteria and making an exopolysaccharide from the bacteria by submerged aerobic fermentation of the bacteria utilizing a sugar substrate. In addition, the present invention provides a method of producing bacterial exopolysaccharides by fermentation from sugar substrates that the wild-type bacteria for producing the exopolysaccharide cannot utilize.Type: GrantFiled: June 12, 1998Date of Patent: February 22, 2000Assignees: Shin-Etsu Bio, Inc., Shin-Etsu Chemical Co., Ltd.Inventors: Thomas J. Pollock, Marcia Mikolajczak, Motohide Yamazaki, Linda Thorne, Richard W. Armentrout
-
Patent number: 5985623Abstract: The present invention relates to DNA segments isolated from Sphingomonas sp. and involved in the biosynthetic production of sphingan polysaccharides to increase the production of the polysaccharide in engineered microorganisms. The present invention also relates to methods of engineering strains of Sphingomonas to produce bacteria which are hyperproducers of sphingan, methods of identifying and utilizing DNA fragments useful to enhance production of sphingan in bacteria and the hyperproducer bacteria.Type: GrantFiled: January 24, 1995Date of Patent: November 16, 1999Assignees: Shin-Etsu Bio, Inc., Shin-Etsu Chemical Co., Ltd.Inventors: Thomas J. Pollock, Motohide Yamazaki, Linda Thorne, Marcia Mikolajczak, Richard W. Armentrout
-
Patent number: 5912151Abstract: A method of increasing xanthan gum production, comprising culturing a Xanthomonas campestris strain having a xanthan-increasing modification in a culture medium, wherein the modification is selected from the group consisting of (1) a mutation causing rifampicin-resistance; (2) a mutation causing bacitracin-resistance; or (3) exogenous genetic information controlling the synthesis of xanthan; and separating xanthan from the culture medium, is provided along with specific DNA sequences and Xanthomonas campestris strains showing increased xanthan gum production.Type: GrantFiled: January 24, 1992Date of Patent: June 15, 1999Assignees: Shin-Etsu Chemical Co., Ltd., Shin-Etsu Bio, Inc.Inventors: Thomas J. Pollock, Linda Thorne
-
Patent number: 5854034Abstract: The present invention relates to DNA segments isolated from Sphingomonas sp. and involved in the biosynthetic production of sphingan polysaccharides to increase the production of the polysaccharide in engineered microorganisms. The present invention also relates to methods of engineering strains of Sphingomonas to produce bacteria which are hyperproducers of sphingan, methods of identifying and utilizing DNA fragments useful to enhance production of sphingan in bacteria and the hyperproducer bacteria.Type: GrantFiled: January 24, 1996Date of Patent: December 29, 1998Assignees: Shin-Etsu Cio, Inc., Shin-Etsu Chemical Co., Ltd.Inventors: Thomas J. Pollock, Motohide Yamazaki, Linda Thorne, Marcia Mikolajczak, Richard W. Armentrout
-
Patent number: 5472870Abstract: A method of increasing xanthan gum production, comprising culturing a Xanthomonas campestris strain having a xanthan-increasing modification in a culture medium, wherein the modification is selected from the group consisting of (1) a mutation causing rifampicin-resistance; (2) a mutation causing bacitracin-resistance; or (3) exogenous genetic information controlling the synthesis of xanthan; and separating xanthan from the culture medium, is provided along with specific DNA sequences and Xanthomonas campestris strains showing increased xanthan gum production. The strain is preferably ATCC 55429.Type: GrantFiled: January 27, 1992Date of Patent: December 5, 1995Assignees: Shin-Etsu Chemical Co., Ltd., Shin-Etsu Bio, Inc.Inventors: Thomas J. Pollock, Linda Thorne
-
Patent number: 5340743Abstract: A method of increasing xanthan gum production, comprising culturing a Xanthomonas campestris strain having a xanthan-increasing modification in a culture medium, wherein the modification is selected from the group consisting of (1) a mutation causing rifampicin-resistance; (2) a mutation causing bacitracin-resistance; or (3) exogenous genetic information controlling the synthesis of xanthan; and separating xanthan from the culture medium, is provided along with specific DNA sequences and Xanthomonas campestris strains showing increased xanthan gum production.Type: GrantFiled: February 13, 1992Date of Patent: August 23, 1994Assignees: Shin-Etsu Chemical Co., Ltd., Shin-Etsu Bio, Inc.Inventors: Thomas J. Pollock, Linda Thorne
-
Patent number: 5338841Abstract: A method of increasing xanthan gum production, comprising culturing a Xanthomonas campestris strain having a xanthan-increasing modification in a culture medium, wherein the modification is selected from the group consisting of (1) a mutation causing rifampicinresistance; (2) a mutation causing bacitracin-resistance; or (3) exogenous genetic information controlling the synthesis of xanthan; and separating xanthan from the culture medium, is provided along with specific DNA sequences and Xanthomonas campestris strains showing increased xanthan gum production.Type: GrantFiled: January 24, 1992Date of Patent: August 16, 1994Assignees: Shin-Etsu Chemical Co., Ltd., Shin-Etsu Bio, Inc.Inventors: Thomas J. Pollock, Linda Thorne
-
Patent number: 5310677Abstract: A method of increasing xanthan gum production, comprising culturing a Xanthomonas campestris strain having a xanthan-increasing modification in a culture medium, wherein the modification is selected from the group consisting of (1) a mutation causing rifampicin-resistance; (2) a mutation causing bacitracin-resistance; or (3) exogenous genetic information controlling the synthesis of xanthan; and separating xanthan from the culture medium, is provided along with specific DNA sequences and Xanthomonas campestris strains showing increased xanthan gum production.Type: GrantFiled: November 5, 1992Date of Patent: May 10, 1994Assignees: Shin-Etsu Chemical Co., Ltd., Shin-Etsu Bio, Inc.Inventors: Thomas J. Pollock, Linda Thorne
-
Patent number: 5279961Abstract: A method of increasing xanthan gum production, comprising culturing a Xanthomonas campestris strain having a xanthan-increasing modification in a culture medium, wherein the modification is selected from the group consisting of (1) a mutation causing rifampicin-resistance; (2) a mutation causing bacitracin-resistance; or (3) exogenous genetic information controlling the synthesis of xanthan; and separating xanthan from the culture medium, is provided along with specific DNA sequences and Xanthomonas campestris strains showing increased xanthan gum production.Type: GrantFiled: April 24, 1990Date of Patent: January 18, 1994Assignees: Shin-Etsu Chemical Co., Ltd., Shin-Etsu Bio, Inc.Inventors: Thomas J. Pollock, Linda Thorne
-
Patent number: 5194386Abstract: A method of increasing xanthan gum production, comprising culturing a Xanthomonas campestris strain having a xanthan-increasing modification in a culture medium, wherein the modification is selected from the group consisting of (1) a mutation causing rifampicin-resistance; (2) a mutation causing bacitracin-resistance; or (3) exogenous genetic information controlling the synthesis of xanthan; and separating xanthan from the culture medium, is provided along with specific DNA sequences and Xanthomonas campestris strains showing increased xanthan gum production.Type: GrantFiled: February 13, 1990Date of Patent: March 16, 1993Assignees: Shin-Etsu Chemical Co., Ltd., Shin-Etsu Bio, Inc.Inventors: Thomas J. Pollock, Linda Thorne